Wise Investments

[dsertrat]

SMD...

Here is one of the reasons, with more to follow:

EXTI Receives Patent Notice re Synthetic Liver Device

FRIDAY , NOVEMBER 07, 2003 09:14 AM

Exten Industries Inc. (EXTI) announced that its majority owned subsidiary, Xenogenics Corp., has received a notice of allowance from the U.S. Patent and Trade Office that its Sybiol(R) synthetic bio-liver device patent will be issued in the next few months. The Sybiol synthetic bio-liver is an extra-corporeal device designed to support patients who are waiting for liver transplants, who are suffering from episodic liver disease caused by hepatitis, alcoholism, cancer, or from burn or toxic shock syndrome or other liver trauma.